Relief Therapeutics Holdings AG (NASDAQ:RLFTF) | Finanzwire

Basculer en Français

8296	Companies
114902	Keywords
55332	Articles
62460	Press releases

Headlines Articles Press releases Relief Therapeutics Holdings AG

Home
Companies
Relief Therapeutics Holdings AG

BRIEF

published on 06/03/2024 at 07:05, 5 months 18 days ago

Relief Therapeutics Announces Executive Changes

Board Of Directors Executive Changes Biopharmaceutical Relief Therapeutics Senior Management
PRESS RELEASE

published on 06/03/2024 at 07:00, 5 months 18 days ago

Relief Therapeutics Announces Executive Changes
Relief Therapeutics announces executive changes as interim CEO Michelle Lock completes her mandate and transitions out, along with other key executives. Board to review management for optimal results

Executive Changes Biopharmaceutical Relief Therapeutics Rare Diseases Management Review
BRIEF

published on 05/30/2024 at 07:05, 5 months 22 days ago

Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders

Biopharmaceutical Relief Therapeutics AGM 2024 Shareholders Meeting Geneva
PRESS RELEASE

published on 05/30/2024 at 07:00, 5 months 22 days ago

Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders
Relief Therapeutics Holding SA announced the Notice of Annual General Meeting of Shareholders on June 27, 2024, in Geneva, Switzerland

Shareholders AGM Meeting Relief Therapeutics Geneva
BRIEF

published on 05/08/2024 at 07:05, 6 months 13 days ago

Relief Therapeutics Unveils Reorganized Executive Leadership to Bolster Pipeline Development

Biopharmaceutical Corporate Restructuring Executive Leadership Rare Diseases Pipeline Development
PRESS RELEASE

published on 05/08/2024 at 07:00, 6 months 13 days ago

Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the Company through pipeline development initiatives
Relief Therapeutics strengthens its executive leadership team with new appointments to guide the Company through pipeline development initiatives

Biopharmaceutical Relief Therapeutics Rare Diseases Pipeline Development Executive Leadership Team
BRIEF

published on 04/30/2024 at 07:05, 6 months 21 days ago

Relief Therapeutics Releases Annual Report and Shares Corporate Update

Annual Report 2023 Relief Therapeutics RLF-TD011 RLF-OD032 Phenylketonuria Treatment
PRESS RELEASE

published on 04/30/2024 at 07:00, 6 months 21 days ago

Relief Therapeutics has published its Annual Report
Relief Therapeutics has published its Annual Report for 2023, showcasing commitment to rare disease treatments and innovative developments. Read more on their website

Annual Report Corporate Update Relief Therapeutics Rare Diseases Innovative Treatments
BRIEF

published on 04/26/2024 at 17:35, 6 months 24 days ago

RELIEF THERAPEUTICS Holding SA Announces Approved Resolutions in Extraordinary General Meeting

Shareholders Corporate Governance Extraordinary General Meeting Relief Therapeutics Capital Adjustment
PRESS RELEASE

published on 04/26/2024 at 17:30, 6 months 24 days ago

RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces results of extraordinary general meeting where new board members were elected and decisions on share capital, compensation, and corporate law were approved

Share Capital Board Members Compensation Extraordinary General Meeting RELIEF THERAPEUTICS Holding SA

Accesswire

Published on 11/21/2024 at 13:30, 12 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 12 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 42 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 42 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 42 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 27 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 7 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 27 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 35 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 42 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 44 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 22 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 57 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 57 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE